Randomized phase 2a study of TAS5315, a Bruton’s tyrosine kinase inhibitor, for chronic spontaneous urticaria
Allergology International · 2026-07
DOI: 10.1016/j.alit.2026.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergology International, 2026-07. Verfasst von Michihiro Hide und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hiroshima City Hiroshima Citizen Hospital, Hiroshima City Hospital Organization, Hiroshima, Japan; Department of Dermatolo…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taiho Pharmaceutical Co Ltd.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hiroshima City Hiroshima Citizen Hospital, Hiroshima City Hospital Organization, Hiroshima, Japan; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima Unive…
- Department of Dermatology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
- Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
- Department of Dermatology, Showa Medical University, Tokyo, Japan.
- Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Dermatology, Queen's Square Medical Center, Yokohama, Japan.
Förderung
- Taiho Pharmaceutical Co Ltd
Zitieren
APA
Hide, M., Fukunaga, A., Hayama, K., Inomata, N., Takahagi, S., Omi, T., Igarashi, M., Maruyama, R., & Yagami, A. (2026). Randomized phase 2a study of TAS5315, a Bruton’s tyrosine kinase inhibitor, for chronic spontaneous urticaria. Allergology International. https://doi.org/10.1016/j.alit.2026.06.003
Vancouver
Hide M, Fukunaga A, Hayama K, Inomata N, Takahagi S, Omi T, et al. Randomized phase 2a study of TAS5315, a Bruton’s tyrosine kinase inhibitor, for chronic spontaneous urticaria. Allergology International. 2026. doi:10.1016/j.alit.2026.06.003
BibTeX
@article{Hide2026,
author = {Hide, Michihiro and Fukunaga, Atsushi and Hayama, Koremasa and Inomata, Naoko and Takahagi, Shunsuke and Omi, Tokuya and Igarashi, Masaru and Maruyama, Ryuji and Yagami, Akiko},
title = {Randomized phase 2a study of TAS5315, a Bruton’s tyrosine kinase inhibitor, for chronic spontaneous urticaria},
journal = {Allergology International},
year = {2026},
doi = {10.1016/j.alit.2026.06.003}
}
EUVIMED